Intense and allegedly inaccurate media scrutiny focusing on pelvic mesh products and the string of recent multimillion-dollar verdicts has tainted the Philadelphia jury pool, Johnson & Johnson subsidiary Ethicon has argued in a bid to have upcoming pelvic mesh trials moved out of the Philadelphia area.

Last week, Ethicon, the primary defendant in nearly 90 pelvic mesh cases pending in Philadelphia, filed a motion seeking to either have trials moved to a venue outside the five-county suburban Philadelphia area, or have a “pretrial cooling off-period” before beginning the next trial.